Muted end to FY20, promising FY21 pipeline
22/02/21 -"Smith & Nephew reported an in line Q4/FY20 top line (-7.1%/-12.1%). The Q4 decline was attributable to other reconstruction (-45.6%), knees (-16.2%) and ENT (-33.1%), while Hips surprised with a ..."
Pages
56
Language
English
Published on
22/02/21
You may also be interested by these reports :
26/02/21
Sales momentum accelerated in Q3 driven by improving market conditions and better access to customers’ installation sites – the solutions business ...
25/02/21
Benefiting from new product launches and improving ophthalmic market conditions, both the Surgery and Vision care segments returned to growth in Q4 ...
25/02/21
Benefitting from sustained demand for COVID-19 testing solutions, bioMerieux reported another quarter of double-digit growth in Q4 20. Interestingly, ...
24/02/21
We had been really surprised by the announcement of a cost-cutting programme, which is expected to give Fresenius a nice profitability push by the ...